Index of /wp-content/uploads/2018/12

 NameLast modifiedSizeDescription
 Parent Directory   -  
 pimtemplatebg-1-150x..>2021-03-05 12:11 937  
 pimtemplatebg-150x15..>2021-03-05 12:11 937  
 IBD_PYOC_1800x242-15..>2021-03-05 12:11 1.2K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 1.2K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 1.3K 
 Sample-Letter-of-App..>2021-03-05 12:11 1.6K 
 pimsign-150x70.jpg 2021-03-05 12:11 1.9K 
 pimtemplatebg-1-225x..>2021-03-05 12:11 2.3K 
 pimtemplatebg-225x30..>2021-03-05 12:11 2.3K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 2.4K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 2.4K 
 IBD_PYOC_1800x242-30..>2021-03-05 12:11 2.5K 
 Twitter-image-GettyI..>2021-03-05 12:12 3.2K 
 Sample-Letter-of-Med..>2021-03-05 12:11 3.2K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 3.2K 
 pimsign.jpg 2021-03-05 12:11 3.3K 
 Sample-Letter-of-App..>2021-03-05 12:11 3.6K 
 japlogo.png 2021-03-05 12:11 3.9K 
 Twitter-image-GettyI..>2021-03-05 12:12 4.2K 
 Twitter-image-GettyI..>2021-03-05 12:12 4.2K 
 Twitter-image-GettyI..>2021-03-05 12:12 4.3K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 4.4K 
 AD_Pub-in-Action_279..>2021-03-05 12:10 5.0K 
 Sample-Off-label-Use..>2021-03-05 12:11 5.0K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 5.5K 
 Sample-Letter-of-App..>2021-03-05 12:11 5.7K 
 Sample-Letter-of-Med..>2021-03-05 12:11 5.7K 
 CSH_Checklist_CareCo..>2021-03-05 12:10 6.0K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 6.7K 
 Sample-Off-label-Use..>2021-03-05 12:11 6.8K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 6.8K 
 IBD-slide-resource-1..>2021-03-05 12:11 6.8K 
 Sample-Letter-of-Med..>2021-03-05 12:11 6.9K 
 Monitoring-and-Preve..>2021-03-05 12:11 7.6K 
 Twitter-image-GettyI..>2021-03-05 12:12 7.7K 
 IBD_PYOC_279x192-150..>2021-03-05 12:11 7.7K 
 Twitter-image-GettyI..>2021-03-05 12:12 8.0K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 8.0K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 8.2K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 8.9K 
 Monitoring-and-Preve..>2021-03-05 12:11 9.0K 
 IBD_PYOC_1800x242-76..>2021-03-05 12:11 9.0K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 9.2K 
 Sample-Letter-of-App..>2021-03-05 12:11 9.6K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 9.9K 
 Sample-Letter-of-App..>2021-03-05 12:11 11K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 11K 
 Sample-Off-label-Use..>2021-03-05 12:11 12K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 12K 
 Sample-Letter-of-Med..>2021-03-05 12:11 12K 
 Twitter-image-GettyI..>2021-03-05 12:12 12K 
 Session-2-PHI-150x15..>2021-03-05 12:11 12K 
 Session-5-DAL-150x15..>2021-03-05 12:12 12K 
 Session-4-DAL-150x15..>2021-03-05 12:12 12K 
 Session-3-DAL-150x15..>2021-03-05 12:12 13K 
 Session-5-PHI-150x15..>2021-03-05 12:12 13K 
 Session-3-PHI-150x15..>2021-03-05 12:12 13K 
 pimtemplatebg-1-768x..>2021-03-05 12:11 13K 
 pimtemplatebg-768x10..>2021-03-05 12:11 13K 
 i725-eval-button-150..>2021-03-05 12:11 13K 
 IBD-slide-resource-3..>2021-03-05 12:11 13K 
 Session-2-DAL-150x15..>2021-03-05 12:11 13K 
 Session-4-PHI-150x15..>2021-03-05 12:12 13K 
 pimtemplatebg-1-769x..>2021-03-05 12:11 13K 
 pimtemplatebg-769x10..>2021-03-05 12:11 13K 
 IBD_PYOC_1800x242-10..>2021-03-05 12:11 14K 
 Patients-landing_Get..>2021-03-05 12:11 14K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 14K 
 CSH_Checklist_CareCo..>2021-03-05 12:10 14K 
 Patients-landing_Get..>2021-03-05 12:11 14K 
 Sample-Off-label-Use..>2021-03-05 12:11 15K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 15K 
 HealthcareProvider_l..>2021-03-05 12:11 15K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 15K 
 pimtemplatebg-1.jpg 2021-03-05 12:11 15K 
 pimtemplatebg.jpg 2021-03-05 12:11 15K 
 HealthcareProvider_l..>2021-03-05 12:11 15K 
 Twitter-image-GettyI..>2021-03-05 12:12 15K 
 Sample-Letter-of-App..>2018-12-10 15:36 16K 
 Sample-Letter-of-Med..>2018-12-18 19:28 16K 
 Sample-Letter-of-Med..>2018-12-10 15:36 16K 
 Twitter-image-GettyI..>2021-03-05 12:12 17K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 17K 
 Twitter-image-GettyI..>2021-03-05 12:12 18K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 19K 
 Sample-Letter-of-Med..>2021-03-05 12:11 19K 
 AD_Pub-in-Action_279..>2021-03-05 12:10 21K 
 Monitoring-and-Preve..>2021-03-05 12:11 21K 
 i725-eval-button-300..>2021-03-05 12:11 22K 
 Session-3-DAL-300x16..>2021-03-05 12:12 23K 
 Session-5-PHI-300x16..>2021-03-05 12:12 23K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 23K 
 Session-3-PHI-300x16..>2021-03-05 12:12 23K 
 Session-4-DAL-300x16..>2021-03-05 12:12 24K 
 Session-2-PHI-300x16..>2021-03-05 12:12 24K 
 Session-5-DAL-300x16..>2021-03-05 12:12 24K 
 Monitoring-and-Preve..>2021-03-05 12:11 24K 
 Session-2-DAL-300x16..>2021-03-05 12:11 24K 
 Session-4-PHI-300x16..>2021-03-05 12:12 24K 
 Twitter-image-GettyI..>2021-03-05 12:12 25K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 26K 
 Adalimumab_Dosing-PA..>2018-12-10 15:35 26K 
 Vedolizumab-Prior-Au..>2018-12-10 15:36 27K 
 Patients-landing_Get..>2021-03-05 12:11 29K 
 Twitter-image-GettyI..>2021-03-05 12:12 29K 
 HealthcareProvider_l..>2021-03-05 12:11 30K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 31K 
 IBD_PYOC_279x192.jpg 2021-03-05 12:11 33K 
 Sample-Letter-of-Med..>2021-03-05 12:11 34K 
 Sample-Off-label-Use..>2021-03-05 12:11 35K 
 Sample-Letter-of-App..>2021-03-05 12:11 37K 
 Twitter-image-GettyI..>2021-03-05 12:12 37K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 38K 
 IBD-slide-resource-7..>2021-03-05 12:11 38K 
 HealthcareProvider_l..>2021-03-05 12:11 40K 
 Patients-landing_Get..>2021-03-05 12:11 40K 
 Sample-Off-label-Use..>2021-03-05 12:11 43K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 44K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 48K 
 Sample-Off-label-Use..>2018-12-10 15:36 52K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 55K 
 Twitter-image-GettyI..>2021-03-05 12:12 56K 
 Twitter-image-GettyI..>2021-03-05 12:12 58K 
 IBD-slide-resource-1..>2021-03-05 12:11 59K 
 Monitoring-and-Preve..>2018-12-10 15:36 60K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 70K 
 Monitoring-and-Preve..>2021-03-05 12:11 72K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 74K 
 IBD_PYOC_1800x242.jpg 2021-03-05 12:11 78K 
 Sample-Letter-of-Med..>2021-03-05 12:11 80K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 81K 
 Monitoring-and-Preve..>2021-03-05 12:11 84K 
 Sample-Letter-of-App..>2021-03-05 12:11 84K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 91K 
 Sample-Letter-of-App..>2021-03-05 12:11 92K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 93K 
 i725-eval-button-768..>2021-03-05 12:11 94K 
 Sample-Off-label-Use..>2021-03-05 12:11 95K 
 AD_Pub-in-Action_180..>2021-03-05 12:10 95K 
 Session-3-PHI-768x43..>2021-03-05 12:12 97K 
 Sample-Letter-of-Med..>2021-03-05 12:11 97K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 98K 
 Session-4-DAL-768x43..>2021-03-05 12:12 98K 
 Session-2-DAL-768x43..>2021-03-05 12:12 99K 
 Session-4-PHI-768x43..>2021-03-05 12:12 99K 
 Session-3-DAL-768x43..>2021-03-05 12:12 99K 
 Session-5-PHI-768x43..>2021-03-05 12:12 99K 
 Twitter-image-GettyI..>2021-03-05 12:12 100K 
 Session-2-PHI-768x43..>2021-03-05 12:12 100K 
 Session-5-DAL-768x43..>2021-03-05 12:12 100K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 101K 
 Sample-Letter-of-App..>2021-03-05 12:11 102K 
 Sample-Letter-of-Med..>2021-03-05 12:11 110K 
 Vedolizumab-Prior-Au..>2021-03-05 12:12 114K 
 IBD-slide-resource.png 2021-03-05 12:11 116K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 120K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 128K 
 Sample-Letter-of-App..>2021-03-05 12:11 128K 
 Session-3-DAL.png 2021-03-05 12:12 132K 
 Session-5-PHI.png 2021-03-05 12:12 132K 
 Session-3-PHI.png 2021-03-05 12:12 134K 
 Session-4-DAL.png 2021-03-05 12:12 136K 
 i725-eval-button.png 2021-03-05 12:11 138K 
 Session-2-DAL.png 2021-03-05 12:12 138K 
 Session-4-PHI.png 2021-03-05 12:12 138K 
 Session-2-PHI.png 2021-03-05 12:12 138K 
 Session-5-DAL.png 2021-03-05 12:12 138K 
 Sample-Letter-of-Med..>2021-03-05 12:11 139K 
 Sample-Off-label-Use..>2021-03-05 12:11 143K 
 Monitoring-and-Preve..>2021-03-05 12:11 144K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 148K 
 Sample-Off-label-Use..>2021-03-05 12:11 161K 
 Monitoring-and-Preve..>2021-03-05 12:11 162K 
 Monitoring-and-Preve..>2021-03-05 12:11 162K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 164K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 173K 
 CSH_Checklist_CareCo..>2021-03-05 12:11 174K 
 Adalimumab_Dosing-PA..>2021-03-05 12:10 174K 
 Sample-Off-label-Use..>2021-03-05 12:11 187K 
 Monitoring-and-Preve..>2021-03-05 12:11 194K 
 HealthcareProvider_l..>2021-03-05 12:11 201K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 205K 
 HealthcareProvider_l..>2021-03-05 12:11 205K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 216K 
 Patients-landing_Get..>2021-03-05 12:11 235K 
 Monitoring-and-Preve..>2018-12-10 15:36 236K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 238K 
 Patients-landing_Get..>2021-03-05 12:11 241K 
 HealthcareProvider_l..>2021-03-05 12:11 251K 
 HealthcareProvider_l..>2021-03-05 12:11 279K 
 Patients-landing_Get..>2021-03-05 12:11 292K 
 HealthcareProvider_l..>2021-03-05 12:11 312K 
 Patients-landing_Get..>2021-03-05 12:11 344K 
 IBD-PYOC_-Glossary-a..>2018-12-12 17:45 369K 
 HealthcareProvider_l..>2021-03-05 12:11 394K 
 Patients-landing_Get..>2021-03-05 12:11 399K 
 CSH_Checklist_CareCo..>2018-12-10 15:36 413K 
 Patients-landing_Get..>2021-03-05 12:11 474K 
 Twitter-image-GettyI..>2021-03-05 12:12 613K 
 i713-4-Takeda-IBD-PY..>2021-03-05 12:11 739K 
 Session-5-HE-PHI.pdf 2018-12-10 18:20 813K 
 Session-3-HE-DAL.pdf 2018-12-10 17:28 873K 
 Session-1-Value-in-H..>2018-12-10 18:19 926K 
 Session-1-Value-in-H..>2018-12-10 17:27 935K 
 Session-2-COPD-PHI.pdf 2018-12-10 18:20 1.0M 
 Session-5-COPD-DAL.pdf 2018-12-10 17:28 1.0M 
 CSH_Checklist_CareCo..>2018-12-10 15:35 1.2M 
 Session-3-IFIs-PHI.pdf 2018-12-10 18:20 1.2M 
 HMS-IFI_Dr.-Pappas_v..>2018-12-10 18:20 1.5M 
 Session-4-HF-DAL.pdf 2018-12-10 17:28 1.5M 
 Session-2-T2DM-DAL.pdf 2018-12-10 17:27 1.8M 
 IBD-slide-resource.pptx2018-12-10 15:36 1.9M 
 Session-4-T2DM-PHI.pdf 2018-12-10 18:20 3.4M